相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adverse effects of topical timolol: Safety concerns and implications for dermatologic use
Daniel Jaeho et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology
Lenneke Schrier et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
Theranostic Advances in Vascular Malformations
Valerie Dekeuleneer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations
Anteneh Belayneh et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2020)
Ophthalmic Timolol and Hospitalization for Symptomatic Bradycardia and Syncope: A Case Series
Syed A. Abbas et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Vascular Anomalies Diagnosis of Complicated Anomalies and New Medical Treatment Options
Denise M. Adams et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Patient access to compounded drugs in paediatrics after discharge from a tertiary centre
Marie-Kim Heraut et al.
PAEDIATRICS & CHILD HEALTH (2019)
Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child
Ramrada Lekwuttikarn et al.
JAMA DERMATOLOGY (2019)
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot et al.
NATURE (2018)
Off-label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study
Andrea D. Pratico et al.
CURRENT DRUG SAFETY (2018)
Prescribing propranolol for infantile hemangioma: Assessment of dosing errors
Anastasia O. Kurta et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Pediatric Off-Label and Unlicensed Drug Use and Its Implications
Rajeshwari Gore et al.
CURRENT CLINICAL PHARMACOLOGY (2017)
Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents
Sophie E. R. Horbach et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2016)
Adverse Events in Young and Preterm Infants Receiving Topical Timolol for Infantile Hemangioma
Peter Frommelt et al.
PEDIATRIC DERMATOLOGY (2016)
Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma
Kamalvir Gill et al.
PEDIATRIC DERMATOLOGY (2016)
Awareness, knowledge and views of off-label prescribing in children: a systematic review
S. Balan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Treatment of infantile haemangiomas: recommendations of a European expert group
Peter H. Hoeger et al.
EUROPEAN JOURNAL OF PEDIATRICS (2015)
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
Michel Wassef et al.
PEDIATRICS (2015)
Ethics of Drug Research in the Pediatric Intensive Care Unit
Niina Kleiber et al.
PEDIATRIC DRUGS (2015)
Off-Label Use of Drugs in Children
Daniel A. C. Frattarelli et al.
PEDIATRICS (2014)
Pediatric Information in Drug Product Labeling
Aaron N. Sachs et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Haemangioma of Infancy: Two Case Reports with an Overdose of Propranolol
S. R. Janmohamed et al.
CASE REPORTS IN DERMATOLOGY (2011)
Pharmacy prescription dispensing errors reported to a regional poison control center
SA Seifert et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2002)
A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder
MJ Romano et al.
PEDIATRICS (2001)
分享论文
